Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

Open access
Samuelson, Thomas W., Sarkisian, Steven R., Lubeck, David M., Stiles, Michael C., Duh, Yi-Jing, Romo, Eeke A., Giamporcaro, Jane Ellen, Hornbeak, Dana M., Katz, L. Jay, Bartlett, William, Buznego, Carlos, Johnson, Starck, D'Ambrosio, Francis A., Dehning, Doug, DuBiner, Harvey, Goyal, Raj, Hughes, Bret, Marquis, Robert E., Noecker, Robert, Tauber, Shachar, Perez, Bernard R., Roel, Lawrence, Sarkisian, Steven, Silverstein, Steven, Day, Steven, Solomon, Kerry, Tyson, Farrell, Vold, Steven, Samuelson, Thomas, Simmons, Steven, Stiles, Michael, Nguyen, Quang H., Bashford, Kent P., Flowers, Brian, Flynn, William J., Gira, Joseph, Okeke, Constance, Reiss, George R., Tyson, Sydney L., Parkhurst, Greg, Linn, John, Lubeck, David, Solomon, Jonathan, Singh, Inder Paul, Johnson, R. Duncan, Lin, Christopher, Kim, Joshua W., Crane, Charles J., Cotter, Frank·2019·Ophthalmology

Abstract

PURPOSE: Evaluate the safety and effectiveness of an ab interno implanted (iStent inject) Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination with cataract surgery in subjects with mild to moderate primary open-angle glaucoma (POAG). DESIGN: Prospective, randomized, single-masked, concurrently controlled, multicenter clinical trial. PARTICIPANTS: Eyes with mild to moderate POAG and preoperative intraocular pressure (IOP) ≤24 mmHg on 1 to 3 medications, unmedicated diurnal IOP (DIOP) 21 to 36 mmHg, and cataract requiring surgery. METHODS: After uncomplicated cataract surgery, eyes were randomized 3:1 intraoperatively to ab interno implantation of iStent inject (Model G2-M-IS; treatment group, n = 387) or no stent implantation (control group, n = 118). Subjects were followed through 2 years postoperatively. Annual washout of ocular hypotensive medication was performed. MAIN OUTCOME MEASURES: Effectiveness end points were ≥20% reduction from baseline in month 24 unmedicated DIOP and change in unmedicated month 24 DIOP from baseline. Safety measures included best spectacle-corrected visual acuity (BSCVA), slit-lamp and fundus examinations, gonioscopy, pachymetry, specular microscopy, visual fields, complications, and adverse events. RESULTS: The groups were well balanced preoperatively, including medicated IOP (17.5 mmHg in both groups) and unmedicated DIOP (24.8±3.3 mmHg vs. 24.5±3.1 mmHg in the treatment and control groups, respectively, P = 0.33). At 24 months, 75.8% of treatment eyes versus 61.9% of control eyes experienced ≥20% reduction from baseline in unmedicated DIOP (P = 0.005), and mean reduction in unmedicated DIOP from baseline was greater in treatment eyes (7.0±4.0 mmHg) than in control eyes (5.4±3.7 mmHg; P < 0.001). Of the responders, 84% of treatment eyes and 67% of control eyes were not receiving ocular hypotensive medication at 23 months. Furthermore, 63.2% of treatment eyes versus 50.0% of control eyes had month 24 medication-free DIOP ≤18 mmHg (difference 13.2%; 95% confidence interval, 2.9-23.4). The overall safety profile of the treatment group was favorable and similar to that in the control group throughout the 2-year follow-up. CONCLUSIONS: Clinically and statistically greater reductions in IOP without medication were achieved after iStent inject implantation with cataract surgery versus cataract surgery alone, with excellent safety through 2 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2019.03.006

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 307

Metadata

Authors
Samuelson, T. W., Sarkisian, S. R., Lubeck, D. M., Stiles, M. C., Duh, Y.-J., Romo, E. A., Giamporcaro, J. E., Hornbeak, D. M., Katz, L. J., Bartlett, W., Buznego, C., Johnson, S., D'Ambrosio, F. A., Dehning, D., DuBiner, H., Goyal, R., Hughes, B., Marquis, R. E., Noecker, R., Tauber, S., Perez, B. R., Roel, L., Sarkisian, S., Silverstein, S., Day, S., Solomon, K., Tyson, F., Vold, S., Samuelson, T., Simmons, S., Stiles, M., Nguyen, Q. H., Bashford, K. P., Flowers, B., Flynn, W. J., Gira, J., Okeke, C., Reiss, G. R., Tyson, S. L., Parkhurst, G., Linn, J., Lubeck, D., Solomon, J., Singh, I. P., Johnson, R. D., Lin, C., Kim, J. W., Crane, C. J., & Cotter, F.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2019-06
Volume
126
Issue
6
Pages
811-821
ISSN
0161-6420 (ISSN-L)
OpenAlex
W2921397391
Cited by
307
References
20
FWCI
30.80
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. https://app.cochat.ai/papers/10.1016/j.ophtha.2019.03.006
The paper
Samuelson, T. W., Sarkisian, S. R., Lubeck, D. M., Stiles, M. C., Duh, Y.-J., Romo, E. A., Giamporcaro, J. E., Hornbeak, D. M., Katz, L. J., Bartlett, W., Buznego, C., Johnson, S., D'Ambrosio, F. A., Dehning, D., DuBiner, H., Goyal, R., Hughes, B., Marquis, R. E., Noecker, R., . . . Cotter, F. (2019). Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract. Ophthalmology. https://doi.org/10.1016/j.ophtha.2019.03.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.